KoBioLabs

KoBioLabs LT Debt/Equity

The Long-Term Debt to Equity Ratio of KoBioLabs (348150.KQ) as of Nov 16, 2026 is 0.20. In the previous year, Long-Term Debt to Equity Ratio was 0.23 — a change of -14.43% (lower).

LT Debt/Equity

0.20

YoY

-14.43%

Last updated:

Long-Term Debt to Equity Ratio of KoBioLabs is 2025 0.20 . Long-Term Debt to Equity Ratio of KoBioLabs was 2024 0.23 . It decreases by -14.43% lower compared to the previous year.

The KoBioLabs LT Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

LT Debt/Equity
Date
LT Debt/Equity
Jan 1, 2018
0.00 KRW
Jan 1, 2019
-0.00 KRW
Jan 1, 2020
0.00 KRW
Jan 1, 2021
0.08 KRW
Jan 1, 2022
0.15 KRW
Jan 1, 2023
0.21 KRW
Jan 1, 2024
0.23 KRW
Jan 1, 2025
0.20 KRW
The KoBioLabs LT Debt/Equity history
YEARLT Debt/EquityYoY
0.20-14.43%
0.23+11.22%
0.21+34.90%
0.15+82.77%
0.08+8,099.49%
0.00-175.73%
-0.00—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

KoBioLabs Stock analysis

What does KoBioLabs do? KoBioLabs Inc., headquartered in Seoul, South Korea, operates in the Health Care sector, specializing in biotechnology. The company focuses on research and development of the microbiome, developing products such as Bioviom and Queens henna FOODOLOGY, as well as new microbiome drugs. It provides commissioned research services and sells its products domestically and internationally. Listed on 18 November 2020, KoBioLabs is active in both domestic and overseas markets. KoBioLabs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KoBioLabs stock

Long-Term Debt to Equity Ratio of KoBioLabs is 0.20 in 2025.

Long-Term Debt to Equity Ratio of KoBioLabs changed from 0.23 to 0.20, representing a -14.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt to Equity Ratio KoBioLabs since 2006 – with annual values, charts, and detailed analysis.

The LT Debt/Equity ratio measures long-term financial leverage. It shows how much permanent debt capital is used relative to equity financing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Long-Term Debt to Equity Ratio's KoBioLabs with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — KoBioLabs

All Key Metrics — KoBioLabs